Toni Choueiri
MD
Director, Lank Center for Genitourinary Oncology
👥Biography 个人简介
Dr. Toni Choueiri is a GU oncologist at Dana-Farber and a leading expert in multi-target anti-angiogenic tyrosine kinase inhibitors. He has led pivotal trials of cabozantinib in renal cell carcinoma including METEOR and CABOSUN, exploiting its co-inhibition of VEGFR2, MET, and AXL to overcome adaptive resistance pathways that limit VEGFR-selective agents. His work on combining cabozantinib with nivolumab in CheckMate-9ER has established dual anti-angiogenic plus checkpoint blockade as a first-line RCC standard.
🧪Research Fields 研究领域
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Drew M. Pardoll
Johns Hopkins University
Padmanee Sharma
MD Anderson Cancer Center
Naiyer A. Rizvi
Columbia University Irving Medical Center
关注 Toni Choueiri 的研究动态
Follow Toni Choueiri's research updates
留下邮箱，当我们发布与 Toni Choueiri（Dana-Farber Cancer Institute）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment